{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:15:33Z","timestamp":1787166933492,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.01890","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:49:41Z","timestamp":1565657381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["In vitro Activities of Nemonoxacin and Other Antimicrobial Agents Against Human Mycoplasma and Ureaplasmas Isolates and Their Defined Resistance Mechanisms"],"prefix":"10.3389","volume":"10","author":[{"given":"Na","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wancheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones.","volume":"51","author":"Andersson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijantimicag.2017.05.020","article-title":"16-membered macrolide antibiotics: a review.","volume":"51","author":"Arsic","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1128\/aac.45.6.1923-1927.2001","article-title":"In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.","volume":"45","author":"Barry","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1128\/AAC.44.9.2557-2560.2000","article-title":"In Vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas includingmycoplasma hominis and Ureaplasma urealyticumfluoroquinolone-resistant isolates that have been genetically characterized.","volume":"44","author":"Bebear","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1128\/AAC.41.2.269","article-title":"Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.","volume":"41","author":"Bebear","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1128\/AAC.42.9.2304","article-title":"Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro.","volume":"42","author":"B\u00e9b\u00e9ar","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1128\/AAC.47.10.3323-3325.2003","article-title":"DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.","volume":"47","author":"Bebear","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jac\/dkp218","article-title":"Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.","volume":"64","author":"Beeton","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1128\/AAC.01349-08-1348","article-title":"Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.","volume":"53","author":"Beeton","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jac\/w425","article-title":"Antibiotic resistance among Ureaplasma spp. isolates: cause for concern?.","volume":"72","author":"Beeton","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/clinids\/17.Supplement_1.S148","article-title":"Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns.","volume":"17","author":"Blanchard","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/mdr.2017.0431","article-title":"Prevalence and antimicrobial susceptibility of Ureaplasma spp. and Mycoplasma hominis in asymptomatic individuals in Korea.","volume":"24","author":"Choi","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"B13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1128\/AAC.00683-09-689","article-title":"Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.","volume":"54","author":"Chung","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1128\/AAC.00960-07-967","article-title":"Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines.","volume":"52","author":"Degrange","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/JCM.37.1.14-17.1999","article-title":"Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children.","volume":"37","author":"Dorigo-Zetsma","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1099\/00207713-49-4-1879","article-title":"Phylogenetic analysis of Ureaplasma urealyticum \u2013 support for the establishment of a new species, Ureaplasma parvum.","volume":"49","author":"Fanrong","year":"1999","journal-title":"Microbiol. Soc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/AAC.00671-616","article-title":"Antimicrobial susceptibility and clonality of clinical ureaplasma isolates in the United States.","volume":"60","author":"Fernandez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/AAC.00671-616","article-title":"Antimicrobial susceptibility and clonality of clinical Ureaplasma isolates in the United States.","volume":"60","author":"Fern\u00e1ndez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1586\/14787210.4.5.725","article-title":"Levofloxacin in the treatment of community acquired pneumonia.","volume":"4","author":"File","year":"2010","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/11632780-000000000-00000","article-title":"Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.","volume":"32","author":"Guo","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jdv.15146","article-title":"Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?\u2013a position statement from the European STI guidelines editorial board.","volume":"32","author":"Horner","year":"2018","journal-title":"J. Eur. Acad. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1517\/14656566.2015.978288","article-title":"The potential role of nemonoxacin for treatment of common infections.","volume":"16","author":"Huang","year":"2015","journal-title":"Expert Opin. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/infdis\/173.6.1445","article-title":"Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients.","volume":"173","author":"Ieven","year":"1996","journal-title":"J. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12941-016-0150-154","article-title":"Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.","volume":"15","author":"Kocsis","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/0255-0857.154850","article-title":"Ureaplasma: current perspectives.","volume":"33","author":"Kokkayil","year":"2015","journal-title":"Indian J. Med. Microbial."},{"key":"B26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/14787210.2014.894881","article-title":"Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.","volume":"12","author":"Lai","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1128\/AAC.01197-09-1199","article-title":"Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.","volume":"54","author":"Lauderdale","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1128\/AAC.01684-08-1688","article-title":"Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.","volume":"53","author":"Liu","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","article-title":"Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.","volume":"48","author":"Matsuoka","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/jac\/dky238","article-title":"Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015.","volume":"73","author":"Meygret","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/AAC.00779-07-777","article-title":"Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.","volume":"52","author":"Morozumi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/cid\/cix507","article-title":"Mycoplasma hominis infections transmitted through amniotic tissue product.","volume":"65","author":"Novosad","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1348-0421.2001.tb01293.x","article-title":"Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.","volume":"45","author":"Okazaki","year":"2001","journal-title":"Microbiol. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1128\/JCM.01345-07-1347","article-title":"First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.","volume":"45","author":"Pereyre","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/AAC.48.2.460-465.2004","article-title":"In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.","volume":"48","author":"Pereyre","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1128\/AAC.00895-815","article-title":"Antibiotic susceptibility and sequence type distribution of ureaplasma species isolated from genital samples in Switzerland.","volume":"59","author":"Schneider","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/rmed.1999.0769","article-title":"A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults.","volume":"94","author":"Siegert","year":"2000","journal-title":"Respir. Med."},{"key":"B38","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1128\/JCM.32.6.1464-1469.1994","article-title":"Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene.","volume":"32","author":"Teng","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1128\/AAC.00295-210","article-title":"Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia.","volume":"54","author":"van Rensburg","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","author":"Waites","year":"2011","journal-title":"Methods for Antimicrobial Susceptibility Testing of Human Mycoplasmas. Approved Guideline M43-A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e2008","DOI":"10.1128\/AAC.02008-16","article-title":"In Vitro activities of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and China.","volume":"61","author":"Waites","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-116","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond.","volume":"30","author":"Waites","year":"","journal-title":"Clin. Microb. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CMR.18.4.757-789.2005","article-title":"Mycoplasmas and ureaplasmas as neonatal pathogens.","volume":"18","author":"Waites","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B44","article-title":"Emerging antimicrobial resistance in mycoplasmas of humans and animals","author":"Waites","year":"2014","journal-title":"Mollicutes: Molecular Biology and Pathogenesis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/ers.12.50","article-title":"The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.","volume":"6","author":"Wilson","year":"2012","journal-title":"Expert Rev. Respir. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1128\/AAC.06342-6311","article-title":"Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.","volume":"12","author":"Xiao","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1128\/JCM.01877-09-1879","article-title":"Detection and characterization of human Ureaplasma species and serovars by real-time PCR.","volume":"48","author":"Xiao","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/AAC.01563-08-1568","article-title":"Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.","volume":"53","author":"Xin","year":"2009","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.01890\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T09:48:37Z","timestamp":1610790517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.01890\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2019.01890"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.01890","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"article-number":"1890"}}